Differential effects of CB1 receptor agonism in behavioural tests of unconditioned and conditioned fear in adult male rats

Behavioural Brain Research

Volumn 279, Issue , 2015, Pages 9-16

  Simone, Jonathan J ^a   Green, Matthew R ^a   Hodges, Travis E ^a   McCormick, Cheryl M ^a  

^a BROCK UNIVERSITY   (Canada)

Author keywords

CB1 receptor agonism; CB1 receptor antagonism; Conditioned fear; Physiological stress; Unconditioned fear

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CORTICOSTERONE; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL-2-CHLOROETHYLAMIDE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONDITIONING; CONTROLLED STUDY; CORTICOSTERONE RELEASE; ELEVATED PLUS MAZE TEST; FEAR; MALE; NONHUMAN; OPEN FIELD TEST; RAT; RECALL; REINFORCEMENT; STRESS; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; LONG EVANS RAT; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANXIETY; ARACHIDONIC ACIDS; CONDITIONING (PSYCHOLOGY); CORTICOSTERONE; EXTINCTION, PSYCHOLOGICAL; FEAR; MALE; MENTAL RECALL; MOTOR ACTIVITY; PIPERIDINES; PYRAZOLES; RATS; RATS, LONG-EVANS; RECEPTOR, CANNABINOID, CB1;

EID: 84911456854     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.11.012     Document Type: Article

References (63)

1. Fonseca B.M., Costa M., Almada A., Correia-da-Silva M., Teixeira G.N.A. Endogenous cannabinoids revisited: a biochemistry perspective. Prostaglandins & Other Lipid Mediators 2013, 102-103(228):13-30. 10.1016/j.prostaglandins.2013.02.002.
2. De Petrocellis L., Cascio M.G., Di Marzo V. The endocannabinoid system: a general view and latest additions. British Journal of Pharmacology 2004, 141(5):765-774. 10.1038/sj.bjp.0705666.
3. Gorzalka B.B., Hill M.N., Hillard C.J. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neuroscience and Biobehavioral Reviews 2008, 32(6):1152-1160. 10.1016/j.neubiorev.2008.03.004.
4. Howlett A.C. The cannabinoid receptors. Prostaglandins & Other Lipid Mediators 2002, 68-69:619-631.
5. McLaughlin R.J., Gobbi G. Cannabinoids and emotionality: a neuroanatomical perspective. Neuroscience 2012, 204:134-144. 10.1016/j.neuroscience.2011.07.052.
6. Mechoulam R., Parker L.A. The endocannabinoid system and the brain. Annual Review of Psychology 2013, 64:21-47. 10.1146/annurev-psych-113011-143739.
7. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P., Brusco A., et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Research 2006, 1071(1):10-23. 10.1016/j.brainres.2005.11.035.
8. Onaivi E.S., Ishiguro H., Gong J.P., Patel S., Perchuk A., Meozzi, et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Annals of the New York Academy of Sciences 2006, 1074:514-536. 10.1196/annals.1369.052.
9. Fowler C.J., Holt S., Nilsson O., Jonsson K.O., Tiger G., Jacobsson S.O.P. The endocannabinoid signaling system: pharmacological and therapeutic aspects. Pharmacology, Biochemistry, and Behavior 2005, 81(2):248-262. 10.1016/j.pbb.2005.01.023.
10. Gaetani S., Cuomo V., Piomelli D. Anandamide hydrolysis: a new target for anti-anxiety drugs?. Trends in Molecular Medicine 2003, 9(11):474-478. 10.1016/j.molmed.2003.09.005.
11. Arévalo C., de Miguel R., Hernández-Tristán R. Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Pharmacology, Biochemistry, and Behavior 2001, 70(1):123-131.
12. Haller J., Mátyás F., Soproni K., Varga B., Barsy B., Németh B., et al. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission. The European Journal of Neuroscience 2007, 25(8):2445-2456. 10.1111/j. 1460-9568.2007.05476.x.
13. Hill M.N., Gorzalka B.B. Enhancement of anxiety-like responsiveness to the cannabinoid CB1 receptor agonist HU-210 following chronic stress. European Journal of Pharmacology 2004, 499(3):291-295. 10.1016/j.ejphar.2004.06.069.
14. Pamplona F.A., Prediger R.D.S., Pandolfo P., Takahashi R.N. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology 2006, 188(4):641-649. 10.1007/s00213-006-0514-0.
15. Rubino T., Sala M., Viganò D., Braida D., Castiglioni C., Limonta V., et al. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats. Neuropsychopharmacology 2007, 32(9):2036-2045. 10.1038/sj.npp.1301330.
16. Fogaça M.V., Reis F.M.C.V., Campos A.C., Guimarães F.S. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience. European Neuropsychopharmacology 2014, 24(3):410-419. 10.1016/j.euroneuro.2013.10.012.
17. Das R.K., Kamboj S.K., Ramadas M., Yogan K., Gupta V., Redman E., et al. Cannabidiol enhances consolidation of explicit fear extinction in humans. Psychopharmacology 2013, 226(4):781-792. 10.1007/s00213-012-2955-y.
18. Mechoulam R., Peters M., Murillo-Rodriguez E., Hanus L.O. Cannabidiol-recent advances. Chemistry & Biodiversity 2007, 4(8):1678-1692. 10.1002/cbdv.200790147.
19. Tasker J. Endogenous cannabinoids take the edge off neuroendocrine responses to stress. Endocrinology 2004, 145(12):5429-5430. 10.1210/en. 2004-1218.
20. Arenos J.D., Musty R.E., Bucci D.J. Blockade of cannabinoid CB1 receptors alters contextual learning and memory. European Journal of Pharmacology 2006, 539(3):177-183. 10.1016/j.ejphar.2006.04.017.
21. McCormick C.M., Green M.R. From the stressed adolescent to the anxious and depressed adult: investigations in rodent models. Neuroscience 2013, 249:242-257. 10.1016/j.neuroscience.2012.08.063.
22. Wall P.M., Messier C. Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neuroscience and Biobehavioral Reviews 2001, 25(3):275-286.
23. Cruz A.P.M., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacology Biochemistry and Behavior 1994, 49(1):171-176.
24. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neuroscience & Biobehavioral Reviews 1997, 21(6):801-810.
25. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology 2003, 463(1-3):3-33. 10.1016/S0014-2999(03)01272-X.
26. Cohen J. Statistical power analysis for the behavioral sciences 1988, Lawrence Erlbaum Associates, Hillsdale, NJ. 2nd ed.
27. Litvin Y., Phan A., Hill M.N., Pfaff D.W., McEwen B.S. CB1 receptor signaling regulates social anxiety and memory. Genes, Brain, and Behavior 2013, 12(5):479-489. 10.1111/gbb.12045.
28. Sink K.S., Segovia K.N., Sink J., Randall P.A., Collins L.E., Correa M., et al. Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142. European Neuropsychopharmacology 2010, 20(2):112-122. 10.1016/j.euroneuro.2009.11.002.
29. Griebel G., Stemmelin J., Scatton B. Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents. Biological Psychiatry 2005, 57(3):261-267.
30. Guimaraes F.S., Chiaretti T.M., Graeff F.G., Zuardi A.W. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology 1990, 100:558-559.
31. Marco E.M., Perez-Alvarez L., Borcel E., Rubio M., Guaza C., Ambrosio E., et al. Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. Behavioural Pharmacology 2004, 15(1):21-27.
32. Ruehle S., Rey A.A., Remmers F., Lutz B. The endocannabinoid system in anxiety, fear memory and habituation. Journal of Psychopharmacology 2012, 26(1):23-39. 10.1177/0269881111408958.
33. Moreira F.A., Aguiar D.C., Terzian A.L.B., Guimarães F.S., Wotjak C.T. Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?. Neuroscience 2012, 204:186-192. 10.1016/j.neuroscience.2011.08.046.
34. Edwards J.G. TRPV1 in the central nervous system: synaptic plasticity, function, and pharmacological implications. Capsaicin as a therapeutic molecule 2014, 77-104. Springer, Basel. 10.1007/978-3-0348-0828-6. O.M.E. Abdel-Salam (Ed.).
35. Aguiar D.C., Terzian A.L.B., Guimarães F.S., Moreira F.A. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. Psychopharmacology 2009, 205(2):217-225. 10.1007/s00213-009-1532-5.
36. Hakimizadeh E., Oryan S., Hajizadeh Moghaddam A., Shamsizadeh A., Roohbakhsh A. Endocannabinoid system and TRPV1 receptors in the dorsal hippocampus of the rats modulate anxiety-like behaviors. Iranian Journal of Basic Medical Sciences 2012, 15(3):795-802.
37. Moreira F.A., Aguiar D.C., Campos A.C., Lisboa S.F., Terzian A.L., Resstel L.B., et al. Antiaversive effects of cannabinoids: is the periaqueductal gray involved?. Neural Plasticity 2009, 1-11. 10.1155/2009/625469.
38. Terzian A.L.B., Aguiar D.C., Guimarães F.S., Moreira F.A. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray. European Neuropsychopharmacology 2009, 19(3):188-195. 10.1016/j.euroneuro.2008.11.004.
39. Baker C.L., McDougall J.J. The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV1 receptors but not cannabinoid receptors in rat joints. British Journal of Pharmacology 2004, 142(8):1361-1367. 10.1038/sj.bjp.0705902.
40. Casarotto P.C., Terzian A.L.B., Aguiar D.C., Zangrossi H., Guimarães F.S., Wotjak C.T., et al. Opposing roles for cannabinoid receptor type-1 (CB1) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats. Neuropsychopharmacology 2012, 37(2):478-486. 10.1038/npp.2011.207.
41. Fogaça M.V., Aguiar D.C., Moreira F.A., Guimarães F.S. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior. Neuropharmacology 2012, 63(2):202-210. 10.1016/j.neuropharm.2012.03.007.
42. Lee J.L.C., Flavell C.R. Inhibition and enhancement of contextual fear memory destabilization. Frontiers in Behavioral Neuroscience 2014, 8(144):1-9. 10.3389/fnbeh.2014.00144.
43. Reich C.G., Iskander A.N., Weiss M.S. Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats. Journal of Psychopharmacology 2013, 27(10):947-955. 10.1177/0269881113499207.
44. Kochenborger L., Levone B.R., da Silva E.S., Taschetto A.P.D., Terenzi M.G., Paschoalini M.A., et al. The microinjection of a cannabinoid agonist into the accumbens shell induces anxiogenesis in the elevated plus-maze. Pharmacology, Biochemistry, and Behavior 2014, 124C:160-166. 10.1016/j.pbb.2014.05.017.
45. Moreira F.A., Aguiar D.C., Guimarães F.S. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology 2007, 52(3):958-965. 10.1016/j.neuropharm.2006.10.013.
46. Escartín-Pérez R.E., Cendejas-Trejo N.M., Cruz-Martínez A.M., González-Hernández B., Mancilla-Díaz J.M., Florán-Garduño B. Role of cannabinoid CB1 receptors on macronutrient selection and satiety in rats. Physiology & Behavior 2009, 96(4):646-650.
47. Bahremand A., Nasrabady S.E., Shafaroodi H., Ghasemi M., Dehpour A.R. Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB1 agonist ACEA in the pentylenetetrazole-induced seizure in mice. Epilepsy Research 2009, 84(2):110-119.
48. Kim J.J., Jung M.W. Neural circuits and mechanisms involved in Pavlovian fear conditioning: a critical review. Neuroscience and Biobehavioral Reviews 2006, 30(2):188-202. 10.1016/j.neubiorev.2005.06.005.
49. Orsini C.A., Maren S. Neural and cellular mechanisms of fear and extinction memory formation. Neuroscience and Biobehavioral Reviews 2012, 36(7):1773-1802. 10.1016/j.neubiorev.2011.12.014.
50. Abel T., Lattal K.M. Molecular mechanisms of memory acquisition, consolidation and retrieval. Current Opinion in Neurobiology 2001, 11(2):180-187.
51. Myers K.M., Davis M. Mechanisms of fear extinction. Molecular Psychiatry 2007, 12(2):120-150. 10.1038/sj.mp.4001939.
52. Quirk G.J., Garcia R., González-Lima F. Prefrontal mechanisms in extinction of conditioned fear. Biological Psychiatry 2006, 60(4):337-343. 10.1016/j.biopsych.2006.03.010.
53. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008, 33(1):56-72. 10.1038/sj.npp.1301555.
54. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418(6897):530-534. 10.1038/nature00839.
55. Plendl W., Wotjak C.T. Dissociation of within- and between-session extinction of conditioned fear. The Journal of Neuroscience 2010, 30(14):4990-4998. 10.1523/JNEUROSCI. 6038-09.2010.
56. Riebe C.J., Pamplona F., Kamprath K., Wotjak C.T. Fear relief - toward a new conceptual frame work and what endocannabinoids gotta do with it. Neuroscience 2012, 204:159-185.
57. Reich C.G., Mohammadi M.H., Alger B.E. Endocannabinoid modulation of fear responses: learning and state-dependent performance effects. Journal of Psychopharmacology 2008, 22(7):769-777. 10.1177/0269881107083999.
58. Kamprath K., Marsicano G., Tang J., Monory K., Bisogno T., Di Marzo V., et al. Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. The Journal of Neuroscience 2006, 26(25):6677-6686.
59. Niyuhire F., Varvel S.A., Thorpe A.J., Stokes R.J., Wiley J.L., Lichtman A.H. The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific. Psychopharmacology 2007, 191(2):223-231. 10.1007/s00213-006-0650-6.
60. Lin H.C., Mao S.C., Su C.L., Gean P.W. The role of prefrontal cortex CB1 receptors in the modulation of fear memory. Cerebral Cortex 2009, 19(1):165-175. 10.1093/cercor/bhn075.
61. Herman J.P., Ostrander M.M., Mueller N.K., Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2005, 29(8):1201-1213. 10.1016/j.pnpbp.2005.08.006.
62. Kamprath K., Plendl W., Marsicano G., Deussing J.M., Wurst W., Lutz B., et al. Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling. Genes, Brain and Behavior 2009, 8(2):203-211.
63. Patel S., Hillard C.J. Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. European Journal of Neuroscience 2008, 27(11):2821-2829.